Training Program in Immunology and Inflammation

免疫学和炎症培训计划

基本信息

项目摘要

ABSTRACT The Immunology and Inflammation training program at NYU School of Medicine (NYUSoM) provides pre- doctoral and post-doctoral training at the interface between immunology and human disease. The Program trains students and postdoctoral fellows in basic immunology as well as its applications in host- pathogen interactions, autoimmune and inflammatory diseases, and antitumor immunity. A long-term goal of the program is to train a new cadre of researchers in the broad and interdisciplinary area of immunology and its relation to inflammatory processes. The first cycle of the program supported multiple successful trainees, all of whom currently continue training or employment in academic immunology research. The training program currently has 30 faculty who are highly productive scientists with extensive mentoring experience. The faculty mentors all share a common interest in understanding basic immunological mechanisms and how the dysregulation of these mechanisms by genetic and environmental factors leads to disease. In addition, NYUSoM is undertaking a major expansion of its immunology research base at all levels and through multiple departments and centers. To match this existing research strength and ongoing expansion in the field of immunology, we propose a training program with 4 pre-doctoral and 2 post-doctoral positions. The program complements and interacts with other existing training programs at NYUSoM, but provides a unique curriculum and training experience with rigorous courses and seminars in an environment that encourages diversity. Trainees will acquire the ability to critically evaluate scientific data and literature and will develop their writing and presentation skills through participation in the immunology seminar series, work-in-progress presentations, journal clubs and an annual retreat. The successful trainees will represent a new generation of scientists who can contribute to the development of novel therapies to treat inflammatory diseases.
摘要 纽约大学医学院(NYUSoM)的免疫学和炎症培训计划提供 在免疫学和人类疾病之间进行博士和博士后培训。这个 该项目培训学生和博士后基础免疫学及其在宿主中的应用。 病原体相互作用,自身免疫和炎症性疾病,以及抗肿瘤免疫。一个长期的 该方案的目标是培养一支新的研究队伍,在广泛和跨学科的领域 免疫学及其与炎症过程的关系。该计划的第一个周期得到支持 多名成功的实习生,他们目前都在继续接受培训或在学术领域就业 免疫学研究。该培训计划目前有30名教职员工,他们都是高生产率的科学家 有丰富的指导经验。教员导师都有一个共同的兴趣,就是理解 基本的免疫学机制以及这些机制的失调是如何通过遗传和 环境因素会导致疾病。此外,NYUSoM正在进行大规模的扩张 各级免疫学研究基地,通过多个部门和中心。与此相匹配 现有的研究实力和不断扩大的免疫学领域,我们建议培训 该项目有4个博士后和2个博士后职位。该程序与以下各项互补和交互 NYUSoM的其他现有培训计划,但提供独特的课程和培训体验 在一个鼓励多样性的环境中提供严格的课程和研讨会。学员将获得 对科学数据和文献进行批判性评估的能力,并将发展其写作和表达能力 通过参加免疫学系列研讨会、正在进行的工作演示、期刊 俱乐部和一年一度的静修。成功的实习生将代表新一代科学家 有助于开发治疗炎症性疾病的新疗法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Susan Ruth Schwab其他文献

Susan Ruth Schwab的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Susan Ruth Schwab', 18)}}的其他基金

FASEB's The Lysophospholipid and Related Mediators Conference: From Bench to Clinic
FASEB 溶血磷脂及相关介质会议:从实验室到临床
  • 批准号:
    10231613
  • 财政年份:
    2021
  • 资助金额:
    $ 31.45万
  • 项目类别:
Validating Inhibitors of the Immunomodulatory Sphingosine 1-Phosphate Transporter SPNS2
验证免疫调节鞘氨醇 1-磷酸转运蛋白 SPNS2 的抑制剂
  • 批准号:
    10116274
  • 财政年份:
    2020
  • 资助金额:
    $ 31.45万
  • 项目类别:
Validating Inhibitors of the Immunomodulatory Sphingosine 1-Phosphate Transporter SPNS2
验证免疫调节鞘氨醇 1-磷酸转运蛋白 SPNS2 的抑制剂
  • 批准号:
    10348768
  • 财政年份:
    2020
  • 资助金额:
    $ 31.45万
  • 项目类别:
A map of sphingosine 1-phosphate distribution
1-磷酸鞘氨醇分布图
  • 批准号:
    9888299
  • 财政年份:
    2017
  • 资助金额:
    $ 31.45万
  • 项目类别:
Control of sphingosine-1-phosphate distribution.
1-磷酸鞘氨醇分布的控制。
  • 批准号:
    8669540
  • 财政年份:
    2013
  • 资助金额:
    $ 31.45万
  • 项目类别:
Training Program in Immunology and Inflammation
免疫学和炎症培训计划
  • 批准号:
    10204903
  • 财政年份:
    2012
  • 资助金额:
    $ 31.45万
  • 项目类别:
Training Program in Immunology and Inflammation
免疫学和炎症培训计划
  • 批准号:
    10610333
  • 财政年份:
    2012
  • 资助金额:
    $ 31.45万
  • 项目类别:
Training Program in Immunology and Inflammation
免疫学和炎症培训计划
  • 批准号:
    10333959
  • 财政年份:
    2012
  • 资助金额:
    $ 31.45万
  • 项目类别:
Control of sphingosine-1-phosphate distribution.
1-磷酸鞘氨醇分布的控制。
  • 批准号:
    8386910
  • 财政年份:
    2010
  • 资助金额:
    $ 31.45万
  • 项目类别:
Regulation of T cell exit from non-lymphoid tissues
T 细胞从非淋巴组织退出的调节
  • 批准号:
    10660163
  • 财政年份:
    2010
  • 资助金额:
    $ 31.45万
  • 项目类别:

相似海外基金

Understanding how pollutant aerosol particulates impact airway inflammation
了解污染物气溶胶颗粒如何影响气道炎症
  • 批准号:
    2881629
  • 财政年份:
    2027
  • 资助金额:
    $ 31.45万
  • 项目类别:
    Studentship
Nanoengineered hybrid coatings that control inflammation to artificial bone
控制人造骨炎症的纳米工程混合涂层
  • 批准号:
    DP240103271
  • 财政年份:
    2024
  • 资助金额:
    $ 31.45万
  • 项目类别:
    Discovery Projects
SARS-CoV-2-induced dead cell fragments drive viral uptake and inflammation
SARS-CoV-2 诱导的死细胞碎片驱动病毒摄取和炎症
  • 批准号:
    DE240101286
  • 财政年份:
    2024
  • 资助金额:
    $ 31.45万
  • 项目类别:
    Discovery Early Career Researcher Award
Is extracellular ferritin is an endogenous danger signal that exacerbates inflammation?
细胞外铁蛋白是加剧炎症的内源性危险信号吗?
  • 批准号:
    MR/Y014065/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.45万
  • 项目类别:
    Research Grant
Does chronic thyroid inflammation explain persistent symptoms in Hashimoto thyroiditis?
慢性甲状腺炎症是否可以解释桥本甲状腺炎的持续症状?
  • 批准号:
    MR/Z503617/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.45万
  • 项目类别:
    Research Grant
The role of LILRB3-mediated immunomodulation on myeloid cells and exploration of new combination therapy for chronic inflammation and cancer
LILRB3介导的免疫调节对骨髓细胞的作用及慢性炎症和癌症联合治疗的探索
  • 批准号:
    24K18478
  • 财政年份:
    2024
  • 资助金额:
    $ 31.45万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Investigating the role of synovial glycome in the interplay between systemic and joint inflammation.
研究滑膜糖组在全身炎症和关节炎症之间相互作用中的作用。
  • 批准号:
    MR/Y003551/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.45万
  • 项目类别:
    Research Grant
SBIR Phase II: Absolute protein quantitation in in vitro diagnostics for gut inflammation
SBIR II 期:肠道炎症体外诊断中的绝对蛋白质定量
  • 批准号:
    2242174
  • 财政年份:
    2024
  • 资助金额:
    $ 31.45万
  • 项目类别:
    Cooperative Agreement
Cannabinoids, Inflammation/Infection and Microglia: Relation to Brain and Behaviour
大麻素、炎症/感染和小胶质细胞:与大脑和行为的关系
  • 批准号:
    502602
  • 财政年份:
    2024
  • 资助金额:
    $ 31.45万
  • 项目类别:
Understanding the link between bone marrow failure and chronic inflammation through the lens of VEXAS syndrome
从 VEXAS 综合征的角度了解骨髓衰竭与慢性炎症之间的联系
  • 批准号:
    MR/Y011945/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.45万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了